|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| CURRENT ASSETS | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Due from related party | |||||||
| Total Current Assets | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
| CURRENT LIABILITIES | |||||||
| Accounts payable and accrued liabilities | |||||||
| Promissory notes | |||||||
| Total Current Liabilities | |||||||
| TOTAL LIABILITIES | |||||||
| STOCKHOLDERS’ DEFICIT | |||||||
| Common stock, $0.001 par value, 100,000,000 shares authorized; 10,226,000 and 10,126,000 shares issued and outstanding | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Stockholders’ Equity (Deficit) | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
Loading...